UBS Group’s Jin Medical International ZJYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-971
Closed -$1.77K – 11703
2026
Q2
$1.77K Sell
971
-252
-21% -$579 ﹤0.01% 9479
2026
Q1
$2.47K Buy
1,223
+999
+446% +$2.96K ﹤0.01% 9267
2025
Q4
$987 Sell
224
-1,860
-89% -$11K ﹤0.01% 9740
2025
Q3
$23.6K Sell
2,084
-2,608
-56% -$33.3K ﹤0.01% 8047
2025
Q2
$61K Sell
4,692
-3,835
-45% -$58.4K ﹤0.01% 7610
2025
Q1
$127K Sell
8,527
-1,024
-11% -$17K ﹤0.01% 6862
2024
Q4
$149K Buy
9,551
+9,446
+8,996% +$296K ﹤0.01% 6632
2024
Q3
$5.64K Sell
105
-3,551
-97% -$214K ﹤0.01% 8039
2024
Q2
$190K Buy
3,656
+3,644
+30,367% +$230K ﹤0.01% 5689
2024
Q1
$945 Sell
12
-536
-98% -$78.4K ﹤0.01% 8297
2023
Q4
$136K Buy
+548
New +$18.6K ﹤0.01% 6010
2023
Q3
– Sell
-746
Closed -$8.51K – 10046
2023
Q2
$8.51K Buy
+746
New +$5.66K ﹤0.01% 7234

Other funds holding ZJYL

UBS Group's ZJYL Position: Q3 2026 in Review

UBS Group sold out of Jin Medical International (ZJYL) in Q3 2026, closing a stake of 971 shares — an estimated $1.77K sold.

UBS Group first reported a position in ZJYL in Q2 2023 and held it in 12 quarters. The position peaked at $190K in Q2 2024. 2 funds tracked by Wall St. Rank hold ZJYL as of Q3 2026.

  • UBS Group reported no remaining Jin Medical International position as of Q3 2026 after selling out during the quarter.
  • UBS Group sold 971 Jin Medical International shares in Q3 2026, an estimated $1.77K.
  • UBS Group first reported a position in Jin Medical International in Q2 2023 and held it in 12 quarters.
  • UBS Group's Jin Medical International position peaked at $190K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Jin Medical International as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.